Vir Biotechnology, Inc. (85) | Business Finance (13)

Browse by Subcategory

Recent Contracts

Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021 (Filed With SEC on May 6, 2021)
Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 29, 2017 (Filed With SEC on September 3, 2019)
Amended and Restated Warrant, issued to Takeda Ventures, Inc (Filed With SEC on September 3, 2019)
Securities Purchase Agreement between the Registrant, Humabs BioMed SA, the shareholders of Humabs set forth therein, the option-holders of Humabs set forth therein and Fortis... (Filed With SEC on September 3, 2019)
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020 (Filed With SEC on July 6, 2020)
Description of Capital Stock (Filed With SEC on March 26, 2020)
Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019 (Filed With SEC on March 26, 2020)
Form of Underwriting Agreement (Filed With SEC on September 30, 2019)
Form of Common Stock Certificate of the Registrant (Filed With SEC on September 30, 2019)
2019 Employee Stock Purchase Plan (Filed With SEC on September 30, 2019)
2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017 (Filed With SEC on September 3, 2019)